Thromb Haemost 1995; 73(04): 728
DOI: 10.1055/s-0038-1653851
Letters to the Editor
Schattauer GmbH Stuttgart

Plasma D-Dimer as a Marker for Postoperative Deep Venous Thrombosis- A Study after Total Hip or Knee Arthroplasty

Paul D Triffitt
Department of Orthopaedic Surgery, University of Leicester, Leicester, UK
› Author Affiliations
Further Information

Publication History

Received 22 December 1994

Accepted 23 December 1994

Publication Date:
09 July 2018 (online)

 
  • References

  • 1 Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162-1173
  • 2 Colwell CW, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA. Use of Enoxaparin a low-molecular-weight heparin and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. J Bone Joint Surg (Am) 1994; 76: 3-14
  • 3 Francis CW, Ricotta JJ, Evarts CM, Marder VJ. Long-term clinical observations and venous functional abnormalities after asymptomatic venous thrombosis following total hip or knee arthroplasty. Clin Orthop 1988; 232: 271-278
  • 4 Gent M, Roberts RS. A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis. Chest 1986; 89: 396-400
  • 5 Murray DW, Carr AJ, Bulstrode CJ K. Pharmacological prophylaxis and total hip replacement. J Bone Joint Surg [Br] 1995; 77-B: 3-5
  • 6 Trowbridge A, Boese CK, Woodruff B, Brindley Sr HH, Lowry WE, Spiro TE. Incidence of posthospitalization proximal deep venous thrombosis after total hip arthroplasty. A pilot study Clin Orthop 1994; 299: 203-208
  • 7 Warwick D, Williams MH, Bannister G C. Death and thromboembolic disease after total hip replacement. J Bone Joint Surg [Br] 1995; 77-B: 6-10